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Orofacial granulomatosis (OFG) is a rare, idiopathic disorder of the orofacial region. It is clinically characterized by persistent
and/or recurrent enlargement of the soft tissues of the oral and maxillofacial region, often manifesting as labial enlargement and
swelling of intraoral sites such as the gingiva, tongue, and buccal mucosa. Full-thickness mucosal biopsy reveals noncaseating
granulomatous inflammation, similar to Crohn’s disease and sarcoidosis. &us, OFG must be distinguished from other chronic
granulomatous disorders. We report a case of a young female patient who presented with labial and maxillary gingival en-
largement without any identifiable systemic causes, with suggested involvement of environmental triggers.
1. Introduction
&e term orofacial granulomatosis (OFG) was first coined by
Wiesenfeld et al. in 1985 to describe a rare granulomatous
inflammation in the orofacial area in the absence of a systemic
condition [1, 2]. Clinically, OFG presents as lip swelling often
with oral involvement, including the gingiva, tongue, and
buccal mucosa, without a clear origin of pathophysiology [2].
Histologically, the condition is marked by noncaseating
granulomas with lymphocytic infiltrate and epithelioid his-
tiocytes [3]. Perivascular aggregation of histiocytes and
plasma cells may be observed along with dilated lymphatics in
the superficial lamina propria [3]. Early medical intervention
is essential in preventing andminimizing permanent swelling,
functional impairment in speaking and eating, and emotional
distress from aesthetic appearance [2].
2. Case Presentation
A 9-year-old Caucasian female presented to the West Vir-
ginia University otolaryngology clinic with the chief com-
plaint of gradually increasing swelling of her upper and
lower lips which started 4 months prior. &e lip swelling was
reported to be very distressing to the child and her parents.
Prior to presentation at the otolaryngology clinic, the patient
was seen by a pediatric dentist, periodontist, and allergist.
&e patient had a history of excessive thumb sucking,
wearing nail polish, and playing with homemade slime
containing glue, saline, shaving cream, and glitter. &e
patient had a history of mild eczematous skin lesions and
vague rhinitis including nasal congestion, occasional post-
nasal drainage, varying complaints of headaches, and oc-
casional conjunctival pruritus. Seasonal symptoms were
worse in spring time, with the pollens of trees, grasses, and
weeds possibly playing a role. &ere was no contributory
family history, medication history, or history of allergy to
food, drugs, or cosmetics. &e patient did not have any
contributory past medical or surgical history.
Physical examination revealed a symmetrically enlarged,
erythematous upper lip with erythematous and edematous
maxillary anterior gingiva, particularly on the right side
(Figures 1 and 2). &e allergist also noted mild fissures in the
lip area, as well as evidence of cheilitis. &e patient was
prescribed mupirocin ointment for the perioral areas where
the cheilitis was present in order to clear any superficial
infection. &is treatment likely resolved these issues prior to
patient presentation at the otolaryngology clinic.
&e suggested differential diagnosis was Crohn’s disease,
sarcoidosis, tuberculosis, angioedema, and orofacial gran-
ulomatosis. Routine laboratory tests (basic metabolic
panel, complete blood count with differential, erythrocyte
sedimentation rate, hepatic function panel, HAV antibody,
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HCV antibody, HBV envelope antibody and antigen,
C-reactive protein, immunoglobulin panel, C4 complement,
C3 complement, glomerular basement membrane anti-
bodies, and cytoplasmic neutrophil antibodies) were per-
formed and were reported to be within normal limits. No
clinical signs or symptoms of gastrointestinal disease were
present.
A right upper lip incisional biopsy was performed.
Submucosal lymphohistiocytic infiltrate with loose peri-
vascular granulomas were found. &e underlying salivary
gland tissue was prominent with lymphocytic infiltrate with
occasional germinal center formation. Acid-fast bacilli were
not seen on a concentrated smear. &e patient’s history,
physical examination, blood and serum tests, and pathology
results led to a diagnosis of OFG of the upper and lower lip
with maxillary gingival hyperplasia.
&e patient was treated with azithromycin pulses for one
month. &is treatment consisted of 500 milligrams once
daily for 3 days, followed by 4 days of no medication. &is
regimen was followed for a total of 4 weeks as previously
described by De et al. in an effort to avoid corticosteroids
given the parents’ concern for corticosteroid side effects [1].
&e patient saw improvement of symptoms following this
treatment. However, after using a lip gloss containing glitter,
she experienced an exacerbation of her oral swelling and
returned to the clinic. Given the perceived treatment failure,
the patient was subsequently treated with 40milligrams once
daily of prednisone for 2 weeks.&e patient reportedmarked
improvement following oral steroid administration. Once
again, however, the patient experienced an exacerbation of
her OFG following swimming. She was treated again with
the same regimen of oral steroids. In addition, she avoided
foods containing benzoates as well as products containing
glitter, both of which seemed to be triggers for her OFG.&e
patient experienced noticeable improvement in her gingival
hyperplasia and lip swelling following the treatment with
oral steroids and behavioral modifications.
3. Discussion
OFG is a diagnosis of exclusion. A negative history of
gastrointestinal or pulmonary complaints precludes the
need for further consideration of Crohn’s disease or sar-
coidosis, respectively [3]. &e patient did present with many
symptoms of allergic angioedema including nonpitting
edema of the lips and face and history of atopic disease (e.g.,
vague rhinitis and mild eczema) [3]. However, granulo-
matous inflammation is not a feature of angioedema, and
thus this condition could be excluded [2]. Stains of the
biopsy specimen for acid-fast bacilli ruled out mycobacterial
infection. &us, a diagnosis of OFG could be made with
negative findings for other possible conditions. &e patient
was referred to pediatric rheumatology for continued
treatment.
&e etiology and pathogenesis of OFG is unknown.
Many studies suggest a delayed hypersensitivity reaction
with an unlikely genetic component [3]. Several studies have
suggested a link between OFG and food allergy, allergy to
dental materials, and inappropriate immunological response
[3, 4]. In this patient’s case, there appeared to be clear
triggers for exacerbation of labial swelling. Her excessive
thumb sucking may not only exposed the oral region to
irritants, but may also caused trauma in the area that
contributed to excess swelling. &e patient also chose to
eliminate benzoates, often found in food preservatives, from
her diet. Diets free of cinnamon and benzoates have been
shown to provide benefit in 54–78% of patients diagnosed
with OFG, with 23% requiring no adjunctive therapy [5].
However, Campbell et al. more broadly suggested that OFG
is a heterogeneous condition where various triggers exist
that induce a similar inflammatory response in the orofacial
region, and dietary intervention as a monotherapy is not
recommended [6]. It is unclear if the benzoate- or glitter-
containing products were the primary cause of OFG or
simply exacerbated the existing disease process. However,
the slow onset of symptoms does support a possible etiology
of delayed hypersensitivity reaction. Regardless, identifica-
tion of contributing factors and minimizing exposure to
these triggers have been proven to maximize treatment
efficacy. &is presents both the limitation and strength of
this case report. &e temporal connections of the facial
swelling and possible environmental triggers increases the
evidence of immunological pathogenesis. &is finding could
allow more conservative treatment modalities in environ-
mental control and decrease the use of antibiotics, corti-
costeroid, and other immunological modulators. &e
Figure 1: Prominent upper lip swelling with fissures that had
persisted for four months.
Figure 2: Maxillary gingival hypertrophy associated with lip
swelling.
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limitation of this study is the patient was not tested for
immunological responses to the specific suspected triggers
nor were the triggers eliminated sequentially. &erefore, it is
unknown if avoidance of environmental triggers or corti-
costeroids was the effective treatment. Another alternative
would be that the two therapies worked synergistically
achieving the favorable response. Rapid resolution of
symptoms was the goal of her management. While this
practice disallowed identification of a sole trigger, we felt the
clinical improvement of the patient provided strong enough
evidence to support the avoidance of these irritants.
Early diagnosis and management of OFG is essential in
preventing permanent manifestations of the condition.
Repeated bouts of labial edema can result in permanent
induration and swelling that can functionally impair a pa-
tient’s ability to speak or eat, as well as cause a great deal of
emotional distress from facial disfigurement [7, 8]. Spon-
taneous remission of OFG is unlikely [3]. It is important to
continue monitoring patients and to treat with corticoste-
roids in order to prevent permanent change. Steroids have
been shown to be effective in reducing and preventing re-
currence of swelling [3].
Patients diagnosed with OFG are at risk to develop other
symptoms and conditions later. In particular, OFG has been
shown to be an early manifestation of Crohn’s disease, which
may present with gastrointestinal symptoms years later [9].
OFG can also be the first presenting symptom of
Melkersson–Rosenthal Syndrome (MRS) [10]. &is disease
manifests as a triad of recurrent labial enlargement, fissured
tongue, and lower motor neuron facial palsy; histopathology
is consistent with OFG [3]. OFG is often considered a variant
and monosymptomatic form of MRS. Consequently, the
association between OFG and other conditions warrants
persistent clinical surveillance for the development of ad-
ditional signs and symptoms.
4. Conclusion
OFG should be considered in the differential diagnosis for
nonspecific labial swelling in the absence of systemic disease.
&orough history, physical exam, and laboratory in-
vestigation should be performed to exclude other etiologies.
Immediate treatment of OFG can prevent permanent de-
formity in the orofacial region. Corticosteroids are con-
sidered the mainstay treatment for OFG. However,
individual patient reports of dietary or environmental
triggers should be taken into consideration. &e presented
case highlights that avoidance of reported triggers can help
minimize corticosteroid therapy. In addition, continued
monitoring is advised since OFGmay be a precursor to other
related conditions.
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